Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 16, 2003. The report details changes in directors' interests in the company's Ordinary Shares and American Depositary Receipts (ADRs) resulting from employee benefit plan transactions.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on equity transactions within employee trusts and retirement plans.
Material Changes
- May 14, 2003: The GlaxoSmithKline Employee Trust (GSK Trust) transferred 31,678 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
- May 15, 2003: The GSK Trust transferred an additional 15,948 Ordinary Shares to participants in the same share option plan.
- May 15, 2003: The GlaxoSmithKline US Retirement Savings Plan saw a decrease in holdings from 18,640,540 to 18,593,843 Ordinary Share ADRs due to fund movements.
Management Commentary and Risks
The filing notes that Directors Dr. J-P Garnier and Mr. J D Coombe hold interests in the GSK Trust shares in the same capacity as other employees. Similarly, Dr. J P Garnier holds a potential interest in the US Retirement Savings Plan. No specific risks, contingencies, or forward-looking guidance are disclosed in this report.
Investor Verification Points
- Verify the total number of shares transferred to the SmithKline Beecham Employee Share Option Plan 1991 during the reporting period (47,626 shares total).
- Confirm the average price of $42.57 for the ADR transactions in the US Retirement Savings Plan.
- Review the specific holdings of Directors Dr. J-P Garnier and Mr. J D Coombe to understand their indirect exposure via the discretionary trusts.